Bicara Therapeutics Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2024 | $-14.6M | $-14.6M | $4.0K | $1.1M |
| Jun 2024 | $-12.9M | $-12.9M | $19.0K | $1.0M |
| Sep 2024 | $-17.2M | $-17.2M | $8.0K | $2.0M |
| Dec 2024 | $-30.0M | $-30.1M | $40.0K | $3.2M |
| Mar 2025 | $-28.1M | $-28.1M | $0 | $3.5M |
| Jun 2025 | $-25.6M | $-25.6M | $0 | $3.5M |
| Sep 2025 | $-29.2M | $-29.3M | $42.0K | $3.6M |
| Dec 2025 | $-23.9M | $-24.1M | $238.0K | $4.4M |
| Mar 2026 | $-37.5M | $-37.6M | $60.0K | $5.9M |
| Jun 2026 | $-44.2M | $-44.3M | $60.0K | $8.2M |